Farms.com Home   News

Case IH’s New 260 Series Loaded with Tech

Case IH’s New 260 Series Loaded with Tech
Nov 29, 2024
By Ryan Ridley
Assistant Editor, North American Content, Farms.com

Access to Integrated Technology in the Base Offering

There’s a new combine lineup on the marketing, Case IH’s 260 Series. 

These combines feature advanced technology and are available in three models - 7260, 8260, and 9260. 

Farms.com recently spoke to Leo Bose, harvesting segment lead at Case IH, to learn more about this new offering. 

“The feature sets that are integrated into this machine are technology—technology in the base offering of the unit,” explained Bose. 

Designed to improve productivity and reduce stress for operators, this series is packed with innovative features tailored for efficiency and comfort. 

One of the standout features in the 260 Series is its connectivity through FieldOps. This system allows you to monitor the machine and essential yield data, like moisture levels, through Android and Apple devices.  

With this real-time information, you can make quick adjustments on the go, making day-to-day and even minute-by-minute management easier and more effective. 

The cab in the 260 Series includes Dual Pro 1200 displays, with its row guidance technology included in the base. 

Row guidance does exactly what it sounds like, it helps the combine stay aligned with the rows for higher productivity and reducing operator fatigue. 

The 260 Series also emphasizes comfort. The cab features an upgraded seat with heating, cooling, and even a massage function, making it one of the most comfortable on the market.  

To learn more about the combine and to see it up close, watch the below video. 

For those interested in precision agriculture, subscribe here at no cost to the Farms.com Precision Ag Digital Digest released 4x per year. 

View the Fall 2024 Farms.com Precision Agriculture Digital Digest here.




Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.